Cargando…

Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients

Detalles Bibliográficos
Autores principales: Jan, Muhammad Y., Sayegh, Skye E., Webb, Hanna T., Adebiyi, Oluwafisayo, Anderson, Melissa D., Mishler, Dennis P., Yaqub, Muhammad S., Taber, Tim, Sharfuddin, Asif A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233547/
https://www.ncbi.nlm.nih.gov/pubmed/34222731
http://dx.doi.org/10.1016/j.ekir.2021.06.012
_version_ 1783713877007007744
author Jan, Muhammad Y.
Sayegh, Skye E.
Webb, Hanna T.
Adebiyi, Oluwafisayo
Anderson, Melissa D.
Mishler, Dennis P.
Yaqub, Muhammad S.
Taber, Tim
Sharfuddin, Asif A.
author_facet Jan, Muhammad Y.
Sayegh, Skye E.
Webb, Hanna T.
Adebiyi, Oluwafisayo
Anderson, Melissa D.
Mishler, Dennis P.
Yaqub, Muhammad S.
Taber, Tim
Sharfuddin, Asif A.
author_sort Jan, Muhammad Y.
collection PubMed
description
format Online
Article
Text
id pubmed-8233547
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82335472021-06-28 Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients Jan, Muhammad Y. Sayegh, Skye E. Webb, Hanna T. Adebiyi, Oluwafisayo Anderson, Melissa D. Mishler, Dennis P. Yaqub, Muhammad S. Taber, Tim Sharfuddin, Asif A. Kidney Int Rep Research Letter Elsevier 2021-06-26 /pmc/articles/PMC8233547/ /pubmed/34222731 http://dx.doi.org/10.1016/j.ekir.2021.06.012 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Jan, Muhammad Y.
Sayegh, Skye E.
Webb, Hanna T.
Adebiyi, Oluwafisayo
Anderson, Melissa D.
Mishler, Dennis P.
Yaqub, Muhammad S.
Taber, Tim
Sharfuddin, Asif A.
Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients
title Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients
title_full Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients
title_fullStr Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients
title_full_unstemmed Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients
title_short Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients
title_sort bamlanivimab for mild to moderate covid-19 in kidney transplant recipients
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233547/
https://www.ncbi.nlm.nih.gov/pubmed/34222731
http://dx.doi.org/10.1016/j.ekir.2021.06.012
work_keys_str_mv AT janmuhammady bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients
AT sayeghskyee bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients
AT webbhannat bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients
AT adebiyioluwafisayo bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients
AT andersonmelissad bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients
AT mishlerdennisp bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients
AT yaqubmuhammads bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients
AT tabertim bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients
AT sharfuddinasifa bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients